A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Harbour BioMed US, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT05824663
CLN-418 Study on Subjects With Advanced Solid Tumors
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Harbour BioMed US, Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT05306444
- Locations
- ๐บ๐ธ
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
๐บ๐ธFlorida Cancer Specialists, Sarasota, Florida, United States
๐บ๐ธCarolina BioOncology Institute - Cancer Research Centre, Huntersville, North Carolina, United States
A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors
- First Posted Date
- 2019-10-22
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Harbour BioMed US, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04135261
- Locations
- ๐ฆ๐บ
Monash Health, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria, Australia
๐จ๐ณHenan Cancer Hospital, Oncology Department, No. 127 Dongming Road, Jinshui District, Zhengzhou, China
๐จ๐ณYantai Yuhuangding Hospital, Urology Department, 8th Floor, No. 20 Donglu Road, Zhifu District, Yantai, Shandong, China
ยฉ Copyright 2025. All Rights Reserved by MedPath